INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1257716223 fda guide]( "The Final DCT Guidance: I'm Not Mad At It")
The Final DCT Guidance: I'm Not Mad At ItExplore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
![GettyImages-953782406-digital-patients-people-recruit]( "How Rescue Studies Use Direct-To-Patient Strategies To Accelerate Clinical Trial Enrollment")
How Rescue Studies Use Direct-To-Patient Strategies To Accelerate Clinical Trial EnrollmentIf your trial struggles to overcome enrollment bottlenecks, a tech-enabled rescue strategy could be the solution.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Powering Complex Personalized Medicine Oncology Trial")
Powering Complex Personalized Medicine Oncology TrialManaging custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
![Avance]( "Oncology Clinical Trials Key Considerations: Planning For Success")
Oncology Clinical Trials Key Considerations: Planning For SuccessChief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.
-
Precision Medicine In Pediatrics: Biomarkers and Assay Development5/2/2025
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
-
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights4/22/2025
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
-
SCOPE 2026 In The Rear-View Mirror2/18/2026
Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.
-
Solutions To The Challenges Of Oncology Trials5/6/2025
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
-
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology4/11/2025
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1204037710 meeting]( "Castor Professional Services: Your Trial Delivery Partner")
Accelerate clinical trial timelines and ensure audit-readiness with expert-led build models, AI-driven data management, and global participant support designed to streamline your path to submission.
-
![New Anti-Cancer Drug Shows Promising Results With Low Toxicity]( "Bold Thinking Overcomes Oncology Clinical Development Challenges")
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
-
![ai-in-healthcare-GettyImages-1333328712]( "TrialKit AI Timeline Value")
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
![GettyImages-2213261066-patient-nurse-health-care]( "Designed Around Your Needs: Let's Accelerate Enrollment Together")
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
![GettyImages-1174677845-blood work-blood tubes]( "Precision Kitting: Every Sample Matters, Every Detail Counts")
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
